Frontline Immunotherapy Combined With Radiation and Chemotherapy in High Risk Endometrial Cancer
Frontline Immunotherapy Combined With Radiation and Chemotherapy in High Risk Endometrial Cancer
Active, not recruiting · NCT03932409 · Registry updated 2026-05-08Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Frontline Immunotherapy Combined With Radiation and Chemotherapy in High Risk Endometrial Cancer | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, endometrium neoplasm, female reproductive system disorder, female reproductive system neoplasm, neoplasm, uterine disorder | Active, not recruiting | Phase 1 | 2026-05-08 | NCT03932409 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Merck Sharp & Dohme LLC | 650 |
| University of Oklahoma | 146 |
2 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| LSU Health New Orleans | New Orleans | United States | 4 |
| Stephenson Cancer Center | Oklahoma City | United States | 32 |